-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Albireo Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2021.
- Albireo Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $3.55M, a 47.1% decline year-over-year.
- Albireo Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $13.2M, a 25.7% decline year-over-year.
- Albireo Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15.9M, a 9% increase from 2020.
- Albireo Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $14.6M, a 92.9% increase from 2019.
- Albireo Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $7.58M, a 36.6% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)